Skip to main content

Table 3 Most significantly associated SNPs identified in the PLINK analysis

From: GWASeq: targeted re-sequencing follow up to GWAS

Chr: Position rs ID number Feature Base change MAF: Cases (Controls) Gene (distance to nearest genes) Uncorrected p-value (0PCs) FDR corrected (0PCs) Uncorrected (2PCs) FDR corrected (2PCs)
9: 5,980,030 Novel intronic A to G 0.048(0.065) KIAA2026 5.323e–008 0.0002117 1.587e–007 0.0005407
10: 8,542,529 Novel Intergenic T to G 0.016(0.028) LINC00708(232261), LINC00709(775047) 3.576e–007 0.0009478 2.461e–007 0.000734
12: 50,554,103 Novel intronic A to G 0.026(0.033) CERS5 2.926e–007 0.0008725 6.119e–007 0.001622
12: 51,243,510 Novel intronic A to T 0.049(0.057) TMPRSS12 7.362e–008 0.0002509 1.104e–007 0.0004388
14: 54,603,486 rs116055771 Intergenic A to T 0.013(0.022) BMP4(179,932), CDKN3(260,187) 4.085e–011 3.248e–007 2.014e–010 1.602e–006
15: 33,008,360 Novel Intergenic A to C 0.034(0.054) SCG5(19,062), GREM1(1,845) 6.384e–009 3.046e–005 2.652e–008 0.0001265
15: 33,345,877 Novel intronic A to C 0.004(0.011) FMN1 2.048e–011 2.443e–007 6.591e–011 7.861e–007
18: 46,119,756 Novel intronic T to C 0.010(0.021) CTIF 2.128e–009 1.736e–006 5.41e–010 3.226e–006
18: 46,119,757 rs76590328 intronic C to T 0.031(0.054) CTIF 6.103e–013 1.456e–008 1.98e–012 4.724e–008
18: 46,503,254 Novel intronic A to G 0.031(0.057) LOXHD1 2.722e–006 0.006494 4.838e–006 0.01154